Tritiated thymidine labelling in Vitro of human cancer of the breast: Counting error and sampling error
Data up to Jan 2025
Total Citations Per Year
Abstract
References (21)
The pathology of invasive breast cancerA Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4)
1975 • 755 citations
Thymidine Metabolism and Cell Kinetics
1968 • 542 citations
Thymidine metabolism and cell kinetics
1967 • 504 citations
Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication
1977 • 195 citations
Potential Pitfalls of [3H]Thymidine Techniques to Measure Cell Proliferation
1981 • 193 citations
Tritium-Labeled Molecules in Biology and Medicine.
1968 • 189 citations
Kinetic parameters and the course of the disease in breast cancer
1981 • 135 citations
Relationship between proliferative activity and estrogen receptors in breast cancer
1979 • 129 citations
Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.
1979 • 118 citations
Tritiated Thymidine Labeling Index and Response in Human Breast Cancer
1979 • 79 citations
Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.
1978 • 77 citations
Autoradiographic studies of in vitro incorporation of uridine and thymidine by human tumor tissue.
1962 • 74 citations
Tritium-labelled Molecules in Biology and Medicine
1968 • 66 citations
In vitro determination of tritiated thymidine labeling index (LI).Evaluation of a method utilizing hyperbaric oxygen and observations on the li of human mammary carcinoma
1975 • 61 citations
Kinetics of human mammary carcinomas and their correlation with the cancer and the host characteristics
1974 • 57 citations
The cell kinetics of human mammary cancers
1979 • 41 citations
Ambiguity of the thymidine index.
1976 • 32 citations
Variation of receptor status in cancer of the breast
1983 • 29 citations
The relation of thymidine labeling index in human tumors in vitro to the effectiveness of 5-fluorouracil chemotherapy.
1971 • 29 citations
Possible tests for selection of adjuvant systemic therapy in early cancer of the breast
1980 • 20 citations
The errors of thymidine labelling in breast cancer.
1983 • 12 citations